The following data is part of a premarket notification filed by Invitrogen Corporation with the FDA for Aim-v (r) Medium, Model 087-0112.
| Device ID | K022086 |
| 510k Number | K022086 |
| Device Name: | AIM-V (R) MEDIUM, MODEL 087-0112 |
| Classification | Media, Culture, Ex Vivo, Tissue And Cell |
| Applicant | INVITROGEN CORPORATION 3175 STALEY RD. Grand Island, NY 14072 |
| Contact | Keith D Gitterman |
| Correspondent | Keith D Gitterman INVITROGEN CORPORATION 3175 STALEY RD. Grand Island, NY 14072 |
| Product Code | NDS |
| CFR Regulation Number | 876.5885 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2002-06-27 |
| Decision Date | 2002-12-23 |
| Summary: | summary |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 10190302005098 | K022086 | 000 |
| 10190302005081 | K022086 | 000 |
| 10190302014267 | K022086 | 000 |
| 30190302014254 | K022086 | 000 |